A combination of oncolytic HSV-1 and in vitro generated CD103+ dendritic cells induces anti-tumor immune responses in a mouse melanoma model

Research output: Unpublished contribution to conferencePoster

Original languageEnglish
Publication statusUnpublished - 2023
EventInternational cancer immunotherapy conference - Milan, Italy
Duration: 20 Sep 202223 Sep 2023

Conference

ConferenceInternational cancer immunotherapy conference
Abbreviated titleCICON23
Country/TerritoryItaly
CityMilan
Period20/09/2223/09/23

Cite this